-
Spinal robotics company forging new path after spiking $482M plan to go public
Minimally invasive spine device company Accelus is making a "strategic pivot" after it scrapped a previous deal to go public by merging with a special purpose acquisition company. -
100 patients treated in cervical disc clinical trial
One hundred patients have been treated in an ongoing investigational device exemption clinical trial of Spineart USA's Baguera C cervical disc in the single level. -
2-level data out on NuVasive's artificial disc: 4 details
A study published in the Journal of Neurosurgery: Spine supports the effectiveness of NuVasive's Simplify cervical artificial disc at two levels compared to spinal fusion. -
Spine merger scrapped, J&J's Q1 earnings and more: 7 device company notes
A spine company's $30 million investment and six more updates from spine and orthopedic device companies in the last week: -
Saluda Medical adds former Wright Medical CEO to board
Robert Palmisano, who led Wright Medical, was added to Saluda Medical's board of directors. -
AxioMed artificial disc inches closer to FDA approval
AxioMed is progressing toward FDA approval for its viscoelastic for lumbar and cervical disc replacement, the devicemaker said April 19. -
Johnson & Johnson orthopedics sales up 3.5% in Q1: 4 notes
Johnson & Johnson saw first-quarter revenue rise 5 percent, with growth in its orthopedics sales. -
SI-Bone nabs CMS payment for spinal fusion implant
SI-Bone's iFuse Bedrock Granite spine implant received a CMS new technology add-on payment. -
Spine devicemaker lands $30M investment
Carlsmed raised $30 million in series B funding to ramp up commercialization of its personalized spine implants, the devicemaker said April 19. -
17 new spine devices get FDA approval
The FDA granted several spine-related device approvals last month. -
Spine device company scraps merger
Accelus, a minimally invasive spine device company, and CHP Merger Corp., a special purpose acquisition company, have terminated a previously agreed-upon merger of the companies because of market conditions. -
Stryker's layoff plans, Orthofix's new leader and more: 7 device company notes
SeaSpine's newest product launch and four more updates in spine and orthopedic medtech in the last week: -
SeaSpine launches device for more anatomically correct surgery
SeaSpine launched its Reef TA interbody system, the devicemaker said April 11. -
Fuse Medical appoints new CFO
Medical device company Fuse Medical has appointed Lawrence Yellin as CFO and member of its executive board. -
Stryker to lay off 88 Florida employees by end of May
Stryker will lay off 88 employees from its Lakeland, Fla., production facility by the end of May, The Ledger reported April 11. -
Investment firm accuses Stryker of overpaying for acquisitions, 'anomalies' in reporting
An investment management company's claims about Stryker's acquisitions, robotics guidance and other business operations sparked an investigation from a stockholder rights law firm. -
Orthofix names president of global orthopedics: 4 details
Kimberley Elting on April 8 was appointed president of global orthopedics for implant developer Orthofix. -
32 orthopedic devices get FDA approval in March
The FDA granted several orthopedic-related device approvals last month. -
Could Medtronic's spine business be the next medtech spinoff?
Four spinoff companies in the orthopedic medtech industry have been completed or announced in the past year, and analysts predict that Medtronic's spine business might soon follow suit. -
4 spine technologies that promised more than they delivered
Innovation moves at a rapid pace in spine surgery, but hype and marketing around new technologies can sometimes get in front of the science, resulting in less than optimal outcomes for patients and significant steps backward for the technology.
Page 50 of 50